天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片
Shanghai Botanicure Co.,Ltd
Firmenname:
Shanghai Botanicure Co.,Ltd
Telefon:
E-Mail:
linda.zhao@botanicure.com
Nationalit?t:
China
URL:
https://www.botanicure.com
Produkte insgesamt:
68
1
Produktkatalog
Rimegepant
1190363-46-2
C25H33F2NO2Si
(R)-3-METHYLPIPERAZIN-2-ONE
922178-61-8
C5H10N2O
Rimegepant
1373116-06-3
C15H16N6O2
(S)-4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)piperidine-4-carboxamide
1143534-59-1
C15H22ClN3O2
3-Methyl-1,2,4-thiadiazole-5-carbohydrazide
1375066-73-1
C4H6N4OS
Zavegepant
855778-84-6
C14H17ClN2O
Elacestrant
722520-36-7
C17H19NO2
Elacestrant
34841-47-9
C9H8O3
Omaveloxolone (RTA 408)
1474034-05-3
C33H44F2N2O3
Deucravacitinib
1442437-21-9
C5H4N2O4
(S)-tert-butyl 4-(tert-butoxycarbonylamino)-4-(1-(4-chlorophenyl)-3-hydroxypropylcarbamoyl)piperidine-1-carboxylate
1143534-57-9
C25H38ClN3O6
Deucravacitinib
2245111-15-1
C5H5Cl2LiN2O3
Anserine
N-β-Alanyl-3-methyl-L-histidin
584-85-0
C10H16N4O3
Spermidine
4-Azaoctamethylendiamin
124-20-9
C7H19N3
Deucravacitinib
1609394-10-6
C10H12N4O
Rimegepant
1373116-05-2
C16H16F2N2O
Deucravacitinib
1609393-89-6
C6H2Cl2D3N3O
4-Chloro-p-fluorobutyrophenone
4-Chlor-4'-fluorbutyrophenon
3874-54-2
C10H10ClFO
Elacestrant
32263-70-0
C17H16O2
Infigratinib
872509-56-3
C8H9Cl2NO2
1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline, 2,3,6b,7,8,9,10,10a-octahydro-3-methyl-, (6bR,10aS)
313368-85-3
C14H19N3
(2S)-Hydroxy(phenyl)acetic acid-(4aS,9bR)-6-bromo-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole (1:1)
1059630-13-5
C19H21BrN2O3
4-tert-butoxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester
189321-65-1
C16H28N2O6
Deucravacitinib
90564-26-4
C9H9NO5
Macitentan
146533-41-7
C10H5BrCl2N2
phenyl N-[(E)-(5-nitrofuran-2-yl)methylideneamino]carbamate
313369-25-4
C17H21N3O3
N-Carbethoxy-4-piperidone
Ethyl-4-oxopiperidin-1-carboxylat
29976-53-2
C8H13NO3
Ectoine
96702-03-3
C6H10N2O2
Sodiumtetrahydrojasmonate
1175006-92-4
C12H23NaO3
2(1H)-Quinoxalinone,3,4-dihydro-; 1,2,3,4-Tetrahydro-2-quinoxali
59564-59-9
C8H8N2O
Deucravacitinib
722538-98-9
C8H8N2O4
Infigratinib
872511-34-7
C26H31Cl2N7O3
Infigratinib
872511-35-8
C17H24N6
Deucravacitinib
Cyclopropancarboxamid
6228-73-5
C4H7NO
7-methoxy-2,2-dimethylchroman-6-ylpalmitate
1105025-85-1
C28H46O4
6-bromo-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole hydrochloride
1059630-11-3
C11H12BrClN2
Calcifediol
Calcifediol
19356-17-3
C27H44O2
Zavegepant
1414976-15-0
C11H14ClN3O2
METHYL 4-((TERT-BUTOXYCARBONYL)AMINO)PIPERIDINE-4-CARBOXYLATE
115655-44-2
C12H22N2O4
4-nitroso-1,3-dihydroquinoxalin-2-one
53374-52-0
C8H7N3O2
(3S)-3-amino-3-(4-chlorophenyl)propanoic acid
131690-60-3
C9H10ClNO2
Elacestrant
860034-09-9
C7H8BNO5
Deucravacitinib
679406-03-2
C7H6Cl2N2O2
DIPALMITOYL HYDROXYPROLINE
trans-1-(1-Oxohexadecyl)-4-[(1-oxohexadecyl)oxy]-L-prolin
41672-81-5
C37H69NO5
Deucravacitinib
1352925-63-3
C7H8N2O4
Macitentan
706811-25-8
C10H7BrN2O2
Elacestrant
722536-73-4
C17H15BrO
Deucravacitinib
1609394-05-9
C9H8N4O3
Deucravacitinib
1609394-08-2
C10H10N4O3
Cholesterol
Cholesterin
57-88-5
C27H46O
Fezolinetant
1429560-52-0
C16H24N2O3
Lumateperone
313369-16-3
C16H19N3O3
DIAMINOPYRIMIDINE OXIDE
C4H6N4O
(3S)-3-amino-3-(4-chlorophenyl)propan-1-ol
886061-26-3
C9H12ClNO
Macitentan
1393813-43-8
C15H19BrN4O4S
Infigratinib
115619-01-7
C12H19N3
(6bR,10aS)-Ethyl 3-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(9H)-carboxylate
313369-26-5
C17H23N3O2
Fisetin
3,3',4',7-Tetrahydroxyflavon
528-48-3
C15H10O6
Ergothioneine
L-(+)-Ergothioneine
497-30-3
C9H15N3O2S
Deucravacitinib
649729-45-3
C9H12N2O5
Elacestrant
59557-92-5
C7H8BrNO
4-Chloro-7H-pyrrolo[2,3-d]pyrimidine
3680-69-1
C6H4ClN3
Zavegepant
868707-31-7
C11H10N2O3
Elacestrant
722520-42-5
C19H23NO2
(3R)-4-[(2,4-dimethoxyphenyl)methyl]-3-methylpiperazin-2-one
1383146-20-0
C14H20N2O3
Macitentan
1393813-42-7
C13H14BrClN4O2S
1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(7H)-carboxylic acid, 2,3,9,10-tetrahydro-2-oxo-, ethyl ester
313544-31-9
C16H17N3O3
Deucravacitinib
1609394-23-1
C16H16ClN7O2
1
Copyright 2019 ? ChemicalBook. All rights reserved